These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 2256110

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Early indications of monocrotaline pyrrole-induced lung injury in rats.
    Schultze AE, Wagner JG, White SM, Roth RA.
    Toxicol Appl Pharmacol; 1991 Jun 01; 109(1):41-50. PubMed ID: 2038748
    [Abstract] [Full Text] [Related]

  • 3. An evaluation of procoagulant activity in the peripheral blood of rats treated with monocrotaline pyrrole.
    Schultze AE, Wagner JG, Roth RA.
    Toxicol Appl Pharmacol; 1991 Jul 01; 109(3):421-31. PubMed ID: 1830177
    [Abstract] [Full Text] [Related]

  • 4. Effects of altered platelet number on pulmonary hypertension and platelet sequestration in monocrotaline pyrrole-treated rats.
    White SM, Wagner JG, Roth RA.
    Toxicol Appl Pharmacol; 1989 Jun 15; 99(2):302-13. PubMed ID: 2734793
    [Abstract] [Full Text] [Related]

  • 5. The effect of immunosuppressants and adoptive transfer in monocrotaline pyrrole pneumotoxicity.
    Bruner LH, Bull RW, Roth RA.
    Toxicol Appl Pharmacol; 1987 Oct 15; 91(1):1-12. PubMed ID: 3672514
    [Abstract] [Full Text] [Related]

  • 6. Injury to the isolated, perfused lung by exposure in vitro to monocrotaline pyrrole.
    Hilliker KS, Roth RA.
    Exp Lung Res; 1985 Oct 15; 8(4):201-12. PubMed ID: 4043006
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lactate dehydrogenase activity and isozyme patterns in tissues and bronchoalveolar lavage fluid from rats treated with monocrotaline pyrrole.
    Schultze AE, Gunaga KP, Wagner JG, Hoorn CM, Moorehead WR, Roth RA.
    Toxicol Appl Pharmacol; 1994 Jun 15; 126(2):301-10. PubMed ID: 8209383
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pulmonary hypertension due to monocrotaline pyrrole is reduced by moderate thrombocytopenia.
    Ganey PE, Sprugel KH, White SM, Wagner JG, Roth RA.
    Am J Physiol; 1988 Nov 15; 255(5 Pt 2):H1165-72. PubMed ID: 3189578
    [Abstract] [Full Text] [Related]

  • 11. The effect of dietary restriction and altered sodium intake on the cardiopulmonary toxicity of monocrotaline pyrrole.
    Ganey PE, Fink GD, Roth RA.
    Toxicol Appl Pharmacol; 1985 Mar 30; 78(1):55-62. PubMed ID: 2930913
    [Abstract] [Full Text] [Related]

  • 12. Pulmonary platelet sequestration is increased following monocrotaline pyrrole treatment of rats.
    White SM, Roth RA.
    Toxicol Appl Pharmacol; 1988 Dec 30; 96(3):465-75. PubMed ID: 2974653
    [Abstract] [Full Text] [Related]

  • 13. Hypertrophy and prolonged DNA synthesis in smooth muscle cells characterize pulmonary arterial wall thickening after monocrotaline pyrrole administration to rats.
    Lappin PB, Roth RA.
    Toxicol Pathol; 1997 Dec 30; 25(4):372-80. PubMed ID: 9280120
    [Abstract] [Full Text] [Related]

  • 14. Complement is not involved in monocrotaline pyrrole-induced pulmonary injury.
    Bruner LH, Johnson KJ, Till GO, Roth RA.
    Am J Physiol; 1988 Feb 30; 254(2 Pt 2):H258-64. PubMed ID: 3344816
    [Abstract] [Full Text] [Related]

  • 15. Pulmonary hypertension and ECG changes from monocrotaline pyrrole in the rat.
    Bruner LH, Hilliker KS, Roth RA.
    Am J Physiol; 1983 Aug 30; 245(2):H300-6. PubMed ID: 6224428
    [Abstract] [Full Text] [Related]

  • 16. Lung vascular injury from monocrotaline pyrrole, a putative hepatic metabolite.
    Roth RA, Reindel JF.
    Adv Exp Med Biol; 1991 Aug 30; 283():477-87. PubMed ID: 1906225
    [Abstract] [Full Text] [Related]

  • 17. Lack of effect of deferoxamine, dimethyl sulfoxide, and catalase on monocrotaline pyrrole pulmonary injury.
    Bruner LH, Johnson K, Carpenter LJ, Roth RA.
    J Toxicol Environ Health; 1987 Aug 30; 21(1-2):205-17. PubMed ID: 3573071
    [Abstract] [Full Text] [Related]

  • 18. Alteration of monocrotaline pyrrole-induced cardiopulmonary effects in rats by hydrallazine, dexamethasone or sulphinpyrazone.
    Hilliker KS, Roth RA.
    Br J Pharmacol; 1984 Jun 30; 82(2):375-80. PubMed ID: 6234044
    [Abstract] [Full Text] [Related]

  • 19. Strain differences in the response of Fischer 344 and Sprague-Dawley rats to monocrotaline induced pulmonary vascular disease.
    Pan LC, Wilson DW, Segall HJ.
    Toxicology; 1993 Mar 30; 79(1):21-35. PubMed ID: 8475497
    [Abstract] [Full Text] [Related]

  • 20. Effects of monocrotaline pyrrole on cultured rat pulmonary endothelium.
    Hoorn CM, Wagner JG, Roth RA.
    Toxicol Appl Pharmacol; 1993 Jun 30; 120(2):281-7. PubMed ID: 8511798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.